MAPS

The Multidisciplinary Association for Psychedelic Studies (MAPS) is presented as a key convener in the modern psychedelic research revival: a nonprofit that helped fund research and brought a scattered field into visible contact. Its significance lies not only in the studies associated with the revival, but also in the connections it fostered among university researchers, underground guides, funders, and people who used psychedelics for therapeutic, spiritual, or other purposes.

Research and Institutional Role

By the period described, MAPS was one of four nonprofit organizations funding most of the psychedelic research then under way. The other named supporters were the Heffter Research Institute, the Beckley Foundation, and CSP. The evidence does not specify MAPS’s founding or internal structure, but it shows the organization operating as more than a source of research support: it organized a large conference designed to bring different parts of the field together.

That role mattered in a field whose work had been interrupted after sanctioned psychedelic therapy ended in the 1970s. The renewed research was, in part, an effort to recover questions and knowledge pursued by earlier generations, while repeating experiments under contemporary scientific standards. MAPS’s activity therefore belonged to a revival that had to reconnect research across a long institutional break.

The 2010 Conference

In 2010, MAPS organized a psychedelic science conference in San Jose, with sponsorship from the Heffter Research Institute, the Beckley Foundation, and CSP. Held at a Holiday Inn, it drew more than a thousand people. Scientists presented research, guides from university trials and underground practice attended, and psychonauts came from a range of backgrounds and levels of experience. Therapists interested in incorporating psychedelics into their practices, funders, filmmakers, and entrepreneurs were also present.

The gathering made the field’s breadth visible in one place. Researchers and practitioners did not occupy separate worlds: the conference put formal presentations alongside the knowledge and working experience of guides, as well as the perspectives of people who used psychedelics in their lives. The atmosphere was celebratory, though attendees also voiced concern about renewed efforts to intensify the drug war.

Connecting Research and Practice

The conference offered a rare opportunity to see the underground guide network, whose size and practices had been difficult to establish, as a substantial presence. James Fadiman, a psychologist with experience in earlier psychedelic research, attended on the science track to speak about the value of guided entheogenic journeys. Wondering how many underground guides were in the audience, he called a meeting for the following morning. He expected a handful; about a hundred people arrived. The turnout disclosed a large, dispersed group that had not been apparent from the formal research record.

The guides did not constitute a single organization, but interviews described them as sharing practices, an outlook, and a code of conduct. Many traced professional lineages to earlier therapists, including Timothy Leary, Stanislav Grof, Al M Hubbard, or Leo Zeff. The conference thus served as a point of contact for people whose knowledge had developed partly outside legal university research. Elsewhere in the research revival, university teams also consulted underground guides about practices such as music in guided psilocybin sessions, and some guides helped train new cohorts for university trials.

Reassessing the Earlier Research

MAPS also provides a setting for looking back critically at the first wave of psychedelic research. Rick Doblin, associated with the organization, reconstructed the Concord Prison Experiment decades after Timothy Leary had reported striking reductions in recidivism among participants who received psilocybin. By reviewing outcomes subject by subject, Doblin concluded that the original claims had overstated the findings: there was no statistically significant difference in recidivism between the psilocybin and control groups.

That reassessment illustrates the tension the revival had to manage. Recovering earlier research did not mean accepting every earlier conclusion; historical claims had to be examined for methodological weaknesses as well as potential insight. MAPS’s place in the account consequently joins two forms of work: assembling a field whose participants and expertise had been dispersed, and helping bring its inherited evidence back under scrutiny.